TY  - JOUR
AU  - Montero-Balosa, Mª Carmen
AU  - Limón-Mora, Juan A.
AU  - Leal-Atienza, Ana
AU  - García-Robredo, Beatriz
AU  - Sanchez-Villegas, Pablo
AU  - Isabel-Gómez, Rebeca
AU  - Aguado-Romeo, Mª José
AU  - Luque-Romero, Luis Gabriel
AU  - Molina-López, Mª Teresa
PY  - 2025
DO  - 10.3389/fphar.2025.1548298
SN  - 1663-9812
UR  - https://hdl.handle.net/10668/28555
T2  - Frontiers in Pharmacology
AB  - Objective: The aim of this study was to evaluate the effectiveness and safety of direct oral anticoagulants (DOACs: dabigatran, rivaroxaban, apixaban and edoxaban) and warfarin versus acenocoumarol in patients with atrial fibrillation under real-world...
LA  - en
PB  - Frontiers
KW  - Effectiveness
KW  - Health outcomes
KW  - Oral anticoagulant agents
KW  - Oral direct anticoagulants
KW  - Safety
KW  - Red Andaluza de Medicina Transfusional de Tejidos y Células
KW  - Área de Evaluación de Tecnologías Sanitarias de Andalucía (AETSA)
KW  - Administration, Oral
KW  - Anticoagulants
KW  - Atrial Fibrillation
KW  - Brain Ischemia
KW  - Stroke
TI  - Comparative clinical outcomes of acenocoumarol versus direct oral anticoagulants (DOACs) and warfarin in patients with atrial fibrillation: real-world-evidence (SIESTA-A study)
TY  - research article
VL  - 16
ER  -